Smart Trade Insights
  • Business
  • Economy
  • Investing
  • Politics
Top Posts
What we know about the LaGuardia plane and...
At least 40% of Russia’s oil export capacity...
Stocks rally, oil prices fall amid talk of...
Savannah Guthrie says family is ‘in agony’ in...
Delta suspends specialty services for members of Congress...
Senate Republicans believe they have a solution to...
Trump backs off escalation, but Iran war goes...
America’s wealth gap is growing, and Trump’s policies...
Pentagon will remove media offices after judge reinstates...
U.S. stocks rise, oil prices fall after Trump...
  • Business
  • Economy
  • Investing
  • Politics

Smart Trade Insights

Business

Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

by admin August 17, 2024
August 17, 2024
Lawmakers ask Mark Zuckerberg to show how Facebook, Instagram are addressing illicit drug ads

A bipartisan group of lawmakers sent Meta CEO Mark Zuckerberg a letter on Thursday expressing concern that the company is failing to prevent illicit drug advertisements from running on its platform.

The House members cited recent reports from The Wall Street Journal and nonprofit Tech Transparency Project, which uncovered a flood of ads on Facebook and Instagram that pointed users to third-party services where they could purchase prescription pills, cocaine and other recreational drugs.

“On March 16, 2024, the Wall Street Journal reported that U.S. federal prosecutors have been investigating Meta for facilitating the sale of illicit drugs,” the lawmakers wrote. “Instead of quickly addressing the issue and fully removing the illicit content, on July 31, 2024, the Wall Street Journal again reported that Meta was ‘“running ads on Facebook and Instagram that steer users to online marketplaces for illegal drugs.’”

Most troubling, they wrote, is that Meta continues to run ads despite the company facing an investigation by U.S. federal prosecutors “for facilitating the sale of illicit drugs.”

The letter’s 19 authors include Reps. Tim Walberg (R-Mich.), Gus Bilirakis (R-Fla.), Kathy Castor (D-Fla.) and Lori Trahan (D-Mass.). They noted that the illicit drug ads were “approved and monetized by Meta” and that they were not hidden on the dark web or private social media pages. Media outlets and researchers could easily find the ads, which contained “contained blatant references to illegal drugs,” while Meta’s internal processes apparently missed them.

“Time and time again we have heard from Meta that users come to your platforms because they like the personalization and experiences you provide, and you use sensitive personal information to direct such personalization through content and advertisements,” the lawmakers wrote. “We in Congress, on multiple occasions, have worked to establish data privacy and security protections for Americans but have, in each instance, been met with friction and opposition from Meta with claims that we would drastically disrupt this personalization you are providing.”

They sent Zuckerberg a list of 15 questions intended to uncover more details about how Meta is addressing the problem, and asked him to respond by Sept. 6.

Meta confirmed receipt of the letter and said it plans to respond. The company shared with CNBC the same statement it gave the Journal for its initial story.

“Drug dealers are criminals who work across platforms and communities, which is why we work with law enforcement to help combat this activity. Our systems are designed to proactively detect and enforce against violating content, and we reject hundreds of thousands of ads for violating our drug policies. We continue to invest resources and further improve our enforcement on this kind of content. Our hearts go out to those suffering from the tragic consequences of this epidemic — it requires all of us to work together to stop it.”

This post appeared first on NBC NEWS

previous post
Recalled cucumbers linked to at least 449 illnesses have been pulled from stores, CDC says
next post
Starbucks is giving incoming CEO Brian Niccol $85 million in cash and stock as he departs Chipotle

You may also like

White House freeze on federal aid won’t affect...

January 30, 2025

Amazon cracks down on Prime free shipping sharing

September 4, 2025

Protesters stage sit-in outside New York Stock Exchange...

October 16, 2024

How crazy popcorn buckets became big business for...

February 20, 2025

Home Depot earnings beat Wall Street estimates as...

February 27, 2025

U.S. could take stakes in more firms, White...

August 26, 2025

UnitedHealth CEO suddenly steps down for ‘personal reasons’

May 14, 2025

Shein and Temu see U.S. demand plunge as...

June 6, 2025

FDA declares cucumber-linked Salmonella outbreak over after 155...

August 27, 2024

Elon Musk confirms Tesla has signed a $16.5...

July 29, 2025

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • What we know about the LaGuardia plane and fire truck crash

      March 27, 2026
    • At least 40% of Russia’s oil export capacity halted, Reuters calculations show

      March 27, 2026
    • Stocks rally, oil prices fall amid talk of Iran ceasefire

      March 27, 2026
    • Savannah Guthrie says family is ‘in agony’ in first interview since her mother’s disappearance

      March 26, 2026
    • Delta suspends specialty services for members of Congress amid shutdown-driven TSA delays

      March 26, 2026
    Promotion Image

    banner ads

    Categories

    • Business (954)
    • Economy (839)
    • Investing (4,085)
    • Politics (747)
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2026 smarttradeinsights.com | All Rights Reserved